Devastating Complication of Novel Chemotherapy Agent

Abstract

Multiple myeloma is B-cell neoplastic disease occurring as a result of monoclonal expansion of plasma cells. This lymphoproliferative disease may involve bone marrow and extramedullary soft tissues. It has been treated successfully over the years with chemotherapy. Novel chemotherapeutic agents may result in devastating unknown complication. Herein, we would like to report a case of bilateral vocal cord palsy following Bortezumib in an elderly gentleman with multiple myeloma.